Skip to content

A clinical trial to study the efficacy of pericapsular nerve group blocks with ultrasonography in hip fracture patients

Assessing the efficacy of pericapsular nerve group block with ultrasonography in hip fracture patients: Evidence from emergency department of a tertiary care hospital - PENGHIP-ED Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088021
Enrollment
66
Registered
2025-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Pericapsular Nerve Group Block: Mode of regional analgesia provided using ultrasonography in patients diagnosed with hip fractures in the emergency department. Control Intervention1: In

Sponsors

Department of Emergency MedicineBase Hospital Delhi Cantt
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Conscious patients, aged over 18, presenting with hip fracture to the ED Pain score at presentation (NRS) of 4 or more

Exclusion criteria

Exclusion criteria: Unstable vital signs (SBP less than 90mmHg and Heart rate less than 60/min), Presence of coagulopathies, Pre-existing cognitive impairment or psychiatric diseases, Polytrauma, Infection at the injection site, Polyneuropathy, Presence of prosthesis in the involved limb, History of local anaesthetic allergy, Not giving consent

Design outcomes

Primary

MeasureTime frame
To access the efficacy of pericapsular nerve group block using ultrasonography in patients diagnosed with hip fracture in the emergency department in comparison with conventional intravenous analgesicsTimepoint: Baseline, 30 mins, 1 hour, 2 hours, 6 hours, 12 hours, 24 hours

Secondary

MeasureTime frame
1. To assess the requirement of systemic analgesia as mode of rescue analgesia during the study period 2. To evaluate any possible adverse events following pericapsular nerve group blockTimepoint: Baseline, 30 mins, 1 hour, 2 hours, 6 hours, 12 hours, 24 hours

Countries

India

Contacts

Public ContactDr Vignesh Jayaprakash

Base Hospital Delhi Cantt

shibusasi@gmail.com7507111992

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026